Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the EA-2353 retinitis pigmentosa study is now displayed, including its terminated status and detailed study information.
    Difference
    41%
    Check dated 2026-11-08T11:43:19.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T12:21:10.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T12:40:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:22:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:37.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and signaling restricted access to the study page.
    Difference
    17%
    Check dated 2026-09-20T20:31:46.000Z thumbnail image

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.